Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2004
12/15/2004EP1484967A1 Dihydronepetalactone as insect repellent
12/15/2004EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004EP1399155A4 Small molecules useful in the treatment of inflammatory disease
12/15/2004EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
12/15/2004EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof
12/15/2004EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/15/2004EP1250144B1 Vegetable oil for preparing a composition inhibiting 5$g(a)- reductase activity
12/15/2004EP1226160B1 Novel antiarrhythmic peptides
12/15/2004EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004EP1221937B1 Hybrid matrices and hybrid matrix mixtures
12/15/2004EP1149063B1 Ureido-thiobutyric acid derivatives as ppar-agonists
12/15/2004EP1101494B1 Composition for stimulating the synthesis of the melanic pigment and procedure to obtain it
12/15/2004EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
12/15/2004EP0921785B1 Combination of acid protease enzymes and acidic buffers and uses thereof
12/15/2004EP0630252B1 Pharmaceutical preparation based on rhamnolipid against dermatological diseases
12/15/2004CN1555488A Lymphatic endothelial cells materials and methods
12/15/2004CN1555367A 3-substituted-4-pyrimidone derivatives
12/15/2004CN1555359A Alkyl urea vitamin A protagonist i
12/15/2004CN1555357A Substituied ureaalkyl urea vitamin A protagonist ii
12/15/2004CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations
12/15/2004CN1555266A Hormone replacement therapy
12/15/2004CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier
12/15/2004CN1555252A Topical composition for follicular delivery of an ornithine decarboxylase inhibitor
12/15/2004CN1554665A Production process and use of epidermal cell colyone
12/15/2004CN1554437A Medicinal composition for treating acne and chloasma
12/15/2004CN1554423A External use anti-inflammatory and myogenic medicine of chinese medicine and its preparing method
12/15/2004CN1554418A Capsule for curing acne
12/15/2004CN1554417A Frostbite liquid
12/15/2004CN1554412A Medicinal paste for treating furunculosis, malignant boil and its preparing method
12/15/2004CN1554405A Powder preparation for treating burn and skin trauma
12/15/2004CN1554402A Medicine for treating tinea peids
12/15/2004CN1554392A Medicine for treating mycotic infection beriberi
12/15/2004CN1554390A Chinese medicinal preparation for treating sicca syndrome and its preparing method
12/15/2004CN1554381A Chinese medicine face mask agent for removingacne removing wrinkle, beautifying and whitening
12/15/2004CN1554375A Method for producing Chinese medicine
12/15/2004CN1554373A Medicine for treating brun and scald and preparing method
12/15/2004CN1554372A External use medicine for hemostatic and trauma healing and promoting reunion of fractured bones
12/15/2004CN1554358A Dibutyryl cyclic adenosine monophosphate preparation and preparing method
12/15/2004CN1554347A Therapeutic liquid for treating leuconychia
12/15/2004CN1554325A Use of of aminosubstituted hydroxybenzophenones as photostable uv-filter in cosmetic and pharmaceutical preparations
12/15/2004CN1179970C Purine derivatives
12/15/2004CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications
12/15/2004CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds
12/15/2004CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004CN1179744C Ointment having pain-killing relieving itching, removing toxic substances and promoting granulation function
12/15/2004CN1179743C Sore-eliminating medicine powder and its prepn and usage
12/15/2004CN1179742C Medicine for treating hoariness and alopecia
12/15/2004CN1179739C Burn film-coating agent
12/15/2004CN1179732C Medicine for curing beriberi and running sore and boil and its preparing method
12/15/2004CN1179730C Wound-treating external-use medicine
12/15/2004CN1179724C Medicinal composition containing biphenyl lambral for treating superficial mycosis
12/14/2004US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004US6831106 Vitamin D analogues
12/14/2004US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
12/14/2004US6831091 Anticancer agents
12/14/2004US6831075 Heterocyclic substituted pyrazolones
12/14/2004US6831069 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/14/2004US6831065 Anti-inflammatory compounds and uses thereof
12/14/2004US6830894 Compounds and methods for modulating claudin-mediated functions
12/14/2004US6830754 Amphipatic lipid containing a hydroxy and amide group; and of a surfactant in an aqueous medium; a washing-away type cosmetic composition comprising the dispersion
12/14/2004US6830750 Reduction of oxidative stress factors with Lactobacillus plantarum
12/14/2004CA2235038C Use of a tnf alpha antagonist for treating neurogenic skin redness
12/14/2004CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/14/2004CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom
12/13/2004CA2467768A1 Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like loxl for stimulating the formation of elastic fibres
12/09/2004WO2004106519A2 Mrp8/mrp14 inhibitors and the use thereof for preventing and/or treating hypertrophic scars and keloids
12/09/2004WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use
12/09/2004WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004WO2004106292A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
12/09/2004WO2004105821A1 Scar management composition comprising silicone
12/09/2004WO2004105745A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant
12/09/2004WO2004105741A1 Cosmetic and/or pharmaceutical compositions comprising dimthylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema
12/09/2004WO2004105737A2 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004WO2004105716A1 Lipidic protein-transfer systems and cosmetic/dermatological use thereof
12/09/2004WO2004105492A1 Aqueous compositions for disinfection and/or sterilization
12/09/2004WO2004089390A3 Use of quinquina for the preparation of a medicament stimulating angiogenesis
12/09/2004WO2004084900A8 Topical formulation and use of buspirone
12/09/2004WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
12/09/2004WO2003080582A3 Fredericamycin derivatives
12/09/2004WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004US20040249138 for preparing Solanum alkaloid glycosides; Solanum is subjected to methanol extraction, drying the extract and dissolving in a weak volatile acid and centrifuged, the supernatant is precipitated using a volatile base; high purity
12/09/2004US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004US20040248983 Potent analgesic and antiinflammatory effects; antiinflammatory agents; treatment of pain and inflammation; N-(3-cyclohexylphenyl)-4-hydroxy-3-methoxyphenylacetamide
12/09/2004US20040248953 3-Arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
12/09/2004US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors
12/09/2004US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004US20040248930 Topical composition
12/09/2004US20040248926 Containing tricyclic active agent having ketone and amide functionality
12/09/2004US20040248923 Novel 4-anilinoquinoline-3-carboxamides
12/09/2004US20040248921 Reducing androgen levels; acne, prostate diseases, alopecia, hirsutism; such as 17-chloromethylene-4-aza-5-alpha-estran-3-one
12/09/2004US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004US20040248919 Insulin sensitizers which do not increase triglyceride levels or suppress thyroid hormone axis; such as 7-[3,5-di-tert-butyl-2-(2,2-difluoroethoxy)-phenyl]-4-fluoro-3-methyl-octa-2,4,6-trienoic acid; synthesis; retinoid X receptor (rxr)
12/09/2004US20040248913 (Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators
12/09/2004US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions
12/09/2004US20040248889 Analgesics; synthesis
12/09/2004US20040248874 Anti-microbial composition comprising a metal ion chelating agent